Published from 2007 to 2015, Vaccines for the Future
provided quarterly updates on our efforts to accelerate the development of innovative, safe, effective, and affordable vaccines against pneumonia (pneumococcal disease) and diarrheal disease (rotavirus, Shigella
, enterotoxigenic Escherichia coli),
as well as new vaccines for the global population against influenza, meningitis, polio, and respiratory syncytial virus. It included updates on progress, partnerships, and specific activities related to these projects. This newsletter is no longer being published and has been replaced by two newsletters: Moving the Needle
provides updates on our vaccine development work, and Immunization Matters
focuses on our vaccine uptake and access work.